Hinge Health files for US IPO as healthcare listings gain momentum

Reuters
03-11
UPDATE 3-Hinge Health files for US IPO as healthcare listings gain momentum

Digital physical therapy firm readies New York IPO

California-based firm valued at $6.2 billion in 2021 funding round

Morgan Stanley, Barclays and BofA Securities tapped as lead underwriters

Adds background on company and IPO market in paragraphs 5-6, 10

March 10 (Reuters) - Hinge Health, which provides digital exercise therapy programs to help people manage and overcome muscle and joint pain, on Monday filed for its long-sought New York initial public offering.

The San Francisco, California-based company, which was valued at $6.2 billion in a 2021 funding round, reported a 33.4% increase in revenue for 2024 and a reduction in net losses, according to its IPO paperwork.

Hinge Health, along with some of its existing shareholders, plans to sell shares in this proposed offering. It had earlier planned to go public in 2022.

The IPO comes despite recent stock market volatility due to uncertainty around U.S. trade policies and adds to the growing momentum for healthcare listings.

Healthcare IPOs on U.S. exchanges raised $7.1 billion in 2024, compared with $2.8 billion a year earlier, according to data compiled by LSEG.

Increasingly sedentary lifestyle and an aging population in the U.S. are expected to boost the demand for physical therapy in coming years.

Revenue rose to $390.4 million in 2024, compared with $292.7 million a year earlier, while net losses shrunk to $11.9 million in the same period from $108.1 million a year earlier.

Founded in 2014 by Daniel Perez and Gabriel Mecklenburg, Hinge Health's platform provides comprehensive musculoskeletal care ranging from acute injury treatment to chronic pain management and post-surgical rehabilitation.

Hinge Health competes against Kaia Health Software, Omada Health, Sword Health Technologies and Vori Health. The company caters to employers such as ride-hailing company Lyft LYFT.O, retailer Target TGT.N, and automaker GM GM.N.

It raised $400 million in 2021 funding round led by investment firms Tiger Global and Coatue Management.

Other major shareholders include venture capital firm Insight Venture Partners, Atomico, 11.2 Capital, and Bessemer Venture Partners.

Morgan Stanley, Barclays and BofA Securities are the lead underwriters for the offering.

Hinge Health, which has tapped 14 banks for the IPO, will list on the New York Stock Exchange under the symbol "HNGE."

(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Tasim Zahid)

((ArasuKannagi.Basil@thomsonreuters.com;))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10